Table: Torii Pharmaceutical - 6-MTH parent results
Jul 30 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2021 Jun 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 21.56 19.86 46.40
(+8.5 pct) (-4.0 pct) (+11.3 pct)
Operating 1.79 2.74 4.00
(-34.7 pct) (+841.3 pct) (-15.6 pct)
Recurring 1.85 2.90 4.20
(-36.2 pct) (+620.9 pct) (-15.5 pct)
Net 1.24 1.80 2.80
(-30.9 pct) (-93.1 pct) (-19.9 pct)
EPS 44.30 yen 64.14 yen 99.69 yen
EPS Diluted 64.13 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)